HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
BMS068645
Description
BMS068645 is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.
No brand information found.
